I learned how to develop protocols for the study of Kv7 channels.
Our company is jointly developing a new protocol that enables efficient screening studies to identify modulators of Kv7.2/Kv7.3 channel activity using spider venom peptides. This will advance the understanding of gain-of-function mutations in channel-related epilepsy and potential therapies. *For more details, please refer to the related links. Feel free to contact us for more information.*
Inquire About This Product
basic information
*You can view the detailed content of the article through the related link. For more information, please feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
*You can view the detailed content of the article through the related link. For more information, please feel free to contact us.*
catalog（3）
Download All Catalogs
News about this product（1）
Company information
Sophion Bioscience was founded by a passionate group of electrophysiologists with a common goal of providing objective patch clamp results quickly and accurately, independent of the experimenter's skill. We have grown from a small startup in Denmark to a global company, but our passion and commitment to providing high-performance patch clamp solutions remain unchanged. Through exceptional technical service and application support, we back our customers in achieving their goals. Additionally, with the continuous development of the QPatch and Qube platforms, we ensure uncompromising data quality in a user-friendly environment, from assay setup to data analysis.